Clinical trials
Phase 3 Heart Failure trials in Ukraine
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Janssen Research & Development, LLC | 2 |
| American Regent, Inc. | 1 |
| Bayer | 1 |
| CSL Behring | 1 |
| Cytokinetics | 1 |
| Lexicon Pharmaceuticals | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Scios, Inc. | 1 |
| Vifor Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 13 |
| Stroke | 3 |
| Coronary Artery Disease | 2 |
| Hypertension | 2 |
| Renal Insufficiency, Chronic | 2 |
| Acute Coronary Syndrome | 1 |
| Anemia, Iron-Deficiency | 1 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.